News

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
US FDA approves Moderna’s Covid-19 vaccine, Spikevax in children aged 6 months through 11 years at increased risk for Covid-19 disease: Cambridge, Massachusetts Saturday, July 1 ...
Marc Filippino Like really big tariffs. Donald Trump voice clip If they have to bring the pharmaceuticals into the country, the drugs and other things into the country, they’re gonna be tariffed at a ...